Granted Patent
Utility
US 6,608,201
· Confirmation No. 8288
PROCESS FOR PREPARING 1-SUBSTITUTED, 2-SUBSTITUTED 1H-IMIDAZO[4,5-C]QUINOLIN-4-AMINES
Inventors
John F. Gerster
Woodbury, MN
Kyle J. Lindstrom
Houlton, WI
Attorneys & Agents of Record
Classification
USPC
546/154
C07D471/04
Prosecution
- Examiner
- MORRIS, PATRICIA L
- Art Unit
- 1625
- Customer No.
- 21874
- Docket No.
- 67023DIV5(54610)
- Confirmation No.
- 8288
Publication
- Pub. No.
- US20030119861A1
- Pub. Date
- 2003-06-26
Patent Term Adjustment
-30days
Parent
is a Division of
→
App. 09/974,038
· US 6,465,654
Filed 2001-10-09
· Patented Case
Parent
is a Continuation of
→
App. 09/386,486
· US 6,348,462
Filed 1999-08-27
· Patent Expired Due to NonPayment of Maintenance Fees Under 37 CFR 1.362
Parent
is a Division of
→
App. 09/060,010
· US 5,977,366
Filed 1998-04-14
· Patented Case
Parent
is a Division of
→
App. 08/789,264
· US 5,741,909
Filed 1997-01-28
· Patented Case
Parent
is a Division of
→
App. 08/353,802
· US 5,605,899
Filed 1994-12-12
· Patented Case
Parent
is a Division of
→
App. 07/938,295
· US 5,389,640
Filed 1992-08-28
· Patented Case
Child
is a Division of
→
App. 10/436,905
· US 6,686,472
Filed 2003-05-13
· Patent Expired Due to NonPayment of Maintenance Fees Under 37 CFR 1.362
Child
is a Division of
→
App. 10/731,826
· US 6,790,961
Filed 2003-12-09
· Patent Expired Due to NonPayment of Maintenance Fees Under 37 CFR 1.362
SOLTA MEDICAL, INC.,
PRECISION DERMATOLOGY, INC.,
BAUSCH HEALTH IRELAND LIMITED (F/K/A/ VALEANT PHARMACEUTICALS IRELAND LIMITED),
SALIX PHARMACEUTICALS, INC.,
SALIX PHARMACEUTICALS, LTD,
SANTARUS, INC.,
MEDICIS PHARMACEUTICAL CORPORATION,
HUMAX PHARMACEUTICAL S.A.,
SOLTA MEDICAL IRELAND LIMITED,
BAUSCH & LOMB MEXICO, S.A. DE C.V.,
BAUSCH+LOMB OPS B.V.,
BAUSCH HEALTH AMERICAS, INC.,
BAUSCH HEALTH COMPANIES INC.,
BAUSCH HEALTH HOLDCO LIMITED,
BAUSCH HEALTH MAGYARORSZAG KFT (A/K/A BAUSCH HEALTH HUNGARY LLC),
BAUSCH HEALTH POLAND SPOLKA Z OGRANICZONA ODPOWIEDZIALNOSCIA (F/K/A VALEANT PHARMA POLAND SPOLKA Z OGRANICZONA ODPOWIEDZIALNOSCIA),
BAUSCH HEALTH US, LLC,
BAUSCH HEALTH, CANADA INC. / SANTE BAUSCH, CANADA INC.,
ICN POLFA RZESZOW SPOLKA AKCYJNA (A/K/A ICN POLFA RZESZOW S.A.),
ORAPHARMA, INC.,
PRZEDSIEBIORSTWO FARMACEUTYCZNE JELFA SPOLKA AKCYJNA (A/K/A PRZEDSIEBIORSTWO FARMACEUTYCZNE JELFA S.A.),
SOLTA MEDICAL DUTCH HOLDINGS B.V.,
V-BAC HOLDING CORP.,
VRX HOLDCO LLC,
1261229 B.C. LTD.,
1530065 B.C. LTD.
RELEASE OF SECURITY INTEREST
Recorded 2025-04-08
NOTICE OF SUCCESSION OF AGENCY
Recorded 2015-01-09
SECURITY AGREEMENT
Recorded 2013-04-24
ASSIGNMENT OF ASSIGNOR'S INTEREST
Recorded 2011-12-13
SECOND LIEN GRANT OF SECURITY INTEREST IN UNITED STATES PATENTS AND TRADEMARKS
Recorded 2007-05-11
RELEASE OF FIRST LIEN SECURITY AGREEMENT IN PATENTS
Recorded 2007-05-10
RELEASE OF SECOND LIEN SECURITY AGREEMENT IN PATENTS
Recorded 2007-05-10
FIRST LIEN GRANT OF SECURITY INTEREST IN UNITED STATES PATENTS AND TRADEMARKS
Recorded 2007-05-10
SECOND LIEN GRANT OF SECURITY INTEREST IN UNITED STATES PATENTS AND TRADEMARKS
Recorded 2007-03-23
FIRST LIEN GRANT OF SECURITY INTEREST IN UNITED STATES PATENTS AND TRADEMARKS
Recorded 2007-03-21
ASSIGNMENT OF ASSIGNOR'S INTEREST
Recorded 2007-02-08
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this application's details
Quick Facts
- Patent No.
- US 6,608,201
- App. No.
- 10/238,661
- Filed
- 2002-09-10
- Granted
- 2003-08-19
- Pub. No.
- US20030119861A1
- Examiner
- MORRIS, PATRICIA L
- Art Unit
- 1625
- PTA
- -30 days
External Links